Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Yagi

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
The EMBO Journal|December 16, 2000
TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteinsF Kanai, P A Marignani, D Sarbassova, et al.
Allergy|March 9, 2018
Identification of specifically reduced Th2 cell subsets in allergic rhinitis patients after sublingual immunotherapyF Ihara, D Sakurai, S Yonekura, et al.
Biological & Pharmaceutical Bulletin|February 1, 1997
In vitro and ex vivo anti-human immunodeficiency virus (HIV) activities of a new water-soluble HIV protease inhibitor, R-87366, containing (2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acidT Komai, R Yagi, H Suzuki-Sunagawa, et al.
Bioorganic & Medicinal Chemistry|August 1, 1996
Structure-activity relationships of HIV-1 PR inhibitors containing AHPBA--II. Modification of pyrrolidine ring at P1' prolineT Komai, S Higashida, M Sakurai, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
The EMBO Journal|December 16, 2000
TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteinsF Kanai, P A Marignani, D Sarbassova, et al.
Allergy|March 9, 2018
Identification of specifically reduced Th2 cell subsets in allergic rhinitis patients after sublingual immunotherapyF Ihara, D Sakurai, S Yonekura, et al.
Biological & Pharmaceutical Bulletin|February 1, 1997
In vitro and ex vivo anti-human immunodeficiency virus (HIV) activities of a new water-soluble HIV protease inhibitor, R-87366, containing (2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acidT Komai, R Yagi, H Suzuki-Sunagawa, et al.
Bioorganic & Medicinal Chemistry|August 1, 1996
Structure-activity relationships of HIV-1 PR inhibitors containing AHPBA--II. Modification of pyrrolidine ring at P1' prolineT Komai, S Higashida, M Sakurai, et al.
Pageof 5